Vogelxo(R) ABPM Study in Hypogandal Men
A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy
Sponsor: Upsher-Smith Laboratories
A PHASE4 clinical study on Hypogonadism, Male, this trial is completed. The trial is conducted by Upsher-Smith Laboratories and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Nov 2024 — Present [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jul 2023 — Mar 2024 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Nov 2022 — Jul 2023 [monthly]
Recruiting PHASE4
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE4
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE4
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Upsher-Smith Laboratories
For direct contact, visit the study record on ClinicalTrials.gov .